Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Atypical Squamous Cells of the Cervix 2Squamous Intraepithelial Lesions 1Polyps 1Hyperplasia 1Adenomatous Polyps 1

Interventions

GX-188 vaccine 4human papillomavirus vaccine, L1 type 16, 18 3Human Papillomavirus DNA Tests 3Colposcopy 3Blood Specimen Collection 3Vaccines 2VGX-3100 2Topotecan 2Restraint, Physical 2Paclitaxel 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Cisplatin 2Biopsy 25-aminolevulinic acid hexyl ester 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1poly ICLC 1methyl 5-aminolevulinate 1epigallocatechin gallate 1artesunic acid 1artemisinin 1ZYC101a 1Watchful Waiting 1Vaccines, Synthetic 1Transurethral Resection of Prostate 1Pregnancy Tests 1Pemetrexed 1Papillomavirus Vaccines 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Cervical Dysplasia × Restraint, Physical × Clear all
NCT07480902 2026-03-18

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

Timser SAPI de CV

Phase NA Recruiting
558 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Timser SAPI de CV

Phase NA Withdrawn
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡